Skip to content

Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer

Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer - Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000041642
Enrollment
3531
Registered
2020-10-01
Start date
2020-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Shizuoka Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pancreatic body and/or tail cancer who underwent DP or DP-CAR between 2002 and 2017 Invasive ductal carcinoma was confirmed by pathological examination

Exclusion criteria

Exclusion criteria: Histologic type was other than invasive ductal carcinoma Multiple or asynchronic carcinoma

Design outcomes

Primary

MeasureTime frame
The relationship between overall survival and portal vein resection and/or the portal vein contact of pancreatic body and/or tail cancer, which was evaluated via preoperative computed tomography in the patients of eligible candidates for DP or DP-CAR

Secondary

MeasureTime frame
The relationship between overall survival and preoperative chemo or chemoradiotherapy

Countries

Japan

Contacts

Public ContactYusuke Yamamoto

Kyoto Prefectural University of Medicine Digestive Surgery

yamayu-1@koto.kpu-m.ac.jp075-251-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026